8-K
Current Report
Theriva Biologics, Inc. Filed Acc 0001104659-22-085672
Shareholder rights changed
- Item 3.03 Material modification to rights of security holders
From the SEC's structured data for this filing
Loading tm2222453d1_8k.htm…